Breaking News Instant updates and real-time market news.

NXTC

NextCure

$26.93

-0.175 (-0.65%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55

NextCure management to meet with Piper Jaffray

Meetings to be held in Chicago on October 14, in Denver, CO on October 15 and in Kansas City, MO on October 16 hosted by Piper Jaffray.

  • 16

    Oct

NXTC NextCure
$26.93

-0.175 (-0.65%)

06/03/19
MSCO
06/03/19
INITIATION
Target $25
MSCO
Overweight
Morgan Stanley starts NextCure with an Overweight rating, $25 price target
As previously reported, Morgan Stanley initiated NextCure with an Overweight rating and $25 price target, with analyst Jeffrey Hung telling investors that he sees a rationale to believe NC318 could work as a means to prevent immune suppression by blocking S15. 60-70% of patients do not respond to checkpoint inhibitors, leaving a significant unmet medical need, and NextCure's scientific founder, Dr. Lieping Chen, also discovered PD-L1, giving Hung greater confidence in the rationale for NC318 and NC410, he tells investors.
07/09/19
BOFA
07/09/19
INITIATION
Target $25
BOFA
Buy
NextCure initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Alec Stranahan started NextCure with a Buy rating and $25 price target. The company has developed a unique drug target discovery platform to identify the next generation of immunotherapies, Stranahan tells investors in a research note. Further, the analyst believes NextCure's cash position will likely be sufficient to advance therapies to late stage clinical trials.
07/10/19
PIPR
07/10/19
NO CHANGE
Target $26
PIPR
Overweight
NextCure should be owned ahead of NC318 data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends owning shares of NextCure ahead of the full Phase I data for NC318 and Phase II expansion cohorts in Q4. NC318 targets Siglec-15 and is differentially expressed from PD-L1 on tumor cells, Tenthoff tells investors in a research note. NC318 achieved one partial response and six patients with stable disease for an "impressive" early disease control rate of 54%, adds the analyst. He reiterates an Overweight rating on NextCure with a $26 price target.
09/04/19
PIPR
09/04/19
NO CHANGE
Target $54
PIPR
Overweight
NextCure price target raised to $54 from $26 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff more than doubled his price target for NextCure to $54 from $26 and reiterates an Overweight rating on the shares. The stock closed Wednesday up 7% to $39.43. Enrollment remains ongoing in the Phase I dose escalation study of NC318 targeting Siglec-15 in advanced solid tumors, Tenthoff tells investors in a research note. While early, NC318 has shown initial signs of activity including, adds the analyst. Tenthoff increased his value for NC318 ahead of Phase I data readout in Q4.

TODAY'S FREE FLY STORIES

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

08:46
11/18/19
11/18
08:46
11/18/19
08:46
Conference/Events
The Medicines Co. to host conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$3.00

-1.6 (-34.78%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Recommendations
Limbach Holding analyst commentary  »

Limbach Holding price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$16.79

0.23 (1.39%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Hot Stocks
Embraer says CIAF Leasing signs order for three E190 jets »

Embraer and Cairo-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADT

ADT Inc.

$8.39

0.13 (1.57%)

, APHA

Aphria

$4.25

-0.175 (-3.96%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ADT

ADT Inc.

$8.39

0.13 (1.57%)

APHA

Aphria

$4.25

-0.175 (-3.96%)

RVLV

Revolve Group

$15.46

-0.17 (-1.09%)

HEAR

Turtle Beach

$8.68

-0.18 (-2.03%)

CGC

Canopy Growth

$15.33

-0.515 (-3.25%)

NAK

Northern Dynasty

$0.56

0.0053 (0.96%)

FAZ

Direxion Financial Bear 3x

$30.70

-0.25 (-0.81%)

CBL

CBL & Associates

$1.46

0.01 (0.69%)

CRWD

Crowdstrike

$59.79

6.96 (13.17%)

BLDP

Ballard Power

$6.91

0.33 (5.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

  • 12

    Dec

  • 19

    Dec

08:45
11/18/19
11/18
08:45
11/18/19
08:45
General news
Treasury Action: reports that China may be having second thoughts »

Treasury Action: reports…

TRHC

Tabula Rasa HealthCare

$42.09

1 (2.43%)

08:44
11/18/19
11/18
08:44
11/18/19
08:44
Hot Stocks
Tabula Rasa HealthCare announces pharmacy services agreement with WelbeHealth »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

OKTA

Okta

08:43
11/18/19
11/18
08:43
11/18/19
08:43
Downgrade
Okta rating change  »

Okta downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

HPQ

HP Inc.

$20.17

0.05 (0.25%)

, XRX

Xerox

$38.95

0.295 (0.76%)

08:43
11/18/19
11/18
08:43
11/18/19
08:43
Recommendations
HP Inc., Xerox analyst commentary  »

HP letter to Xerox…

HPQ

HP Inc.

$20.17

0.05 (0.25%)

XRX

Xerox

$38.95

0.295 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 09

    Dec

TBPMF

Tetra Bio Pharma

$0.00

(0.00%)

08:42
11/18/19
11/18
08:42
11/18/19
08:42
Hot Stocks
Tetra Bio Pharma secures financing for Hemp Energy Drink business »

Tetra Bio-Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SG

Sirius International Insurance Group

$7.80

0.1 (1.30%)

08:42
11/18/19
11/18
08:42
11/18/19
08:42
Hot Stocks
Sirius International Insurance Group confirms Frucher as Non-Executive Chairman »

Sirius International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNA

Synaptics

$60.38

-0.04 (-0.07%)

08:41
11/18/19
11/18
08:41
11/18/19
08:41
Hot Stocks
Swisscom launches IPTV media streaming box powered by Synaptics »

Synaptics Incorporated,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPST

Capstone Turbine

$2.60

0.005 (0.19%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Capstone Turbine announces 1 MW project in Colombia with Ecopetrol »

Capstone Turbine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$16.79

0.23 (1.39%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Embraer says Air Peace signs firm order for three additional E195-E2 jets »

Embraer announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$130.73

5.62 (4.49%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

AMRN

Amarin

$23.99

2.5 (11.63%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Conference/Events
Amarin to host conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

CYDY

CytoDyn

$0.00

(0.00%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Hot Stocks
CytoDyn engages LifeSci Public Relations as communications partner »

CytoDyn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$23.39

0.31 (1.34%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Downgrade
Health Insurance Innovations rating change  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMBI

iMedia Brands

$0.64

0.0001 (0.02%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Hot Stocks
iMedia Brands to launch Bulldog shopping network on November 22 »

iMedia Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

ESTC

Elastic

$74.06

1.94 (2.69%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Upgrade
Elastic rating change  »

Elastic upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

AON

Aon plc

$198.67

0.01 (0.01%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Downgrade
Aon plc rating change  »

Aon plc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$259.91

6.14 (2.42%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Hot Stocks
ServiceNow appoints Gina Mastantuono as CFO, says CEO has assumed role »

ServiceNow announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

CTL

CenturyLink

$14.98

0.09 (0.60%)

, INFN

Infinera

$6.70

0.34 (5.35%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Hot Stocks
CenturyLink, Infinera bring terabit capacity to supercomputing network »

CenturyLink (CTL) and…

CTL

CenturyLink

$14.98

0.09 (0.60%)

INFN

Infinera

$6.70

0.34 (5.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

CPA

Copa Holdings

$106.77

-1.94 (-1.78%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Recommendations
Copa Holdings analyst commentary  »

Copa Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

MMC

Marsh & McLennan

$105.50

0.16 (0.15%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Upgrade
Marsh & McLennan rating change  »

Marsh & McLennan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Hot Stocks
Breaking Hot Stocks news story on T-Mobile »

T-Mobile down 1.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.